Why the study?
Does smoking cessation reduce secondary cardiovascular disease events in patients following an acute coronary syndrome or coronary artery revascularization?
Does smoking cessation reduce secondary cardiovascular disease events in patients following an acute coronary syndrome or coronary artery revascularization?
Answers are grounded in this paper and cite their sources.
Smoking cessation, especially when verified by serum cotinine, is associated with a significantly reduced risk of secondary cardiovascular events at 1 year post-ACS or revascularization.
AIMS: To assess the short-term impact of smoking and smoking cessation measured by self-report and by serum cotinine on the risk of secondary cardiovascular disease events (CVD events). METHODS AND RESULTS: Cohort study among participants of an in-patient 3-week rehabilitation programme following an acute coronary syndrome or coronary artery revascularization. Smoking status at baseline was assessed by self-report (beginning of the rehabilitation programme, rehab) and serum cotinine (end of rehab). Active follow-up was conducted one year later. Subsequent CVD events were observed in 139 of the 967 patients. Both self-reported smoking status (odds ratio (OR) compared to continued smokers: recent quitters 0.96, former smokers 0.83, never smokers 0.54, p for trend 0.04) and serum cotinine (OR 0.59 (95% confidence interval (CI) 0.36-0.97) for cotinine-negative compared to cotinine-positive subjects) were associated with the occurrence of a secondary CVD event. After reclassification of all cotinine-positive subjects to continued smokers and cotinine-negative self-reported smokers to recent quitters, this association became even stronger. The OR now reached 0.71 (95% CI interval 0.38-1.33) for recent quitters, 0.64 (0.36-1.11) for former smokers and 0.44 (0.24-0.81) for never smokers (p-value for trend=0.009). CONCLUSION: The benefits of non-smoking and smoking cessation in cardiac patients are beyond controversy and might even be larger than suggested by previous studies which exclusively relied on self-reported smoking status.
No takes yet. Share an insight, caveat, or question.
Twardella et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: